Cutaneous manifestations in chronic myeloid leukemia in chronic phase treated with imatinib

被引:5
|
作者
Khokar, Abbas [1 ]
Malik, Uzma [1 ]
Butt, Ghazala [1 ]
Naumeri, Fatima [2 ]
机构
[1] King Edward Med Univ, Mayo Hosp, Lahore, Pakistan
[2] Jefferson Joint Sch Dist 251, Lahore, Pakistan
关键词
PHILADELPHIA-CHROMOSOME; PATIENT; STI571;
D O I
10.1111/ijd.14562
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Objective The aim of this study was to see the patterns of skin changes in chronic myeloid leukemia (CML) in chronic phase treated with different doses of imatinib. Methods This cross-sectional study was conducted in the Oncology Department of Jinnah Hospital, Lahore, over a period of 6 months. Patients aged 7-70 years diagnosed either by fluorescence in situ hybridization (FISH) for BCR-ABL or cytogenetics for Philadelphia (Ph) chromosomes and consuming different doses of imatinib for the treatment of CML were randomly selected. Skin manifestations were analyzed and recorded on a predesigned proforma by a dermatologist. Results A total of 132 patients were enrolled; 65 male (49.24%) and 67 female (50.75%). Periorbital edema was found in 48.5% of cases, and hyperpigmentaion and melasma were found in 76.5% of cases. Pruritus was diagnosed in 6.8% of cases, alopecia in 5.3% of cases, and photosensitivity in 43.9% of cases. Conclusions It was concluded that imatinib is associated with many adverse cutaneous side effects which should be overcome or reduced by either decreasing the duration of treatment with imatinib or switching to other treatment options.
引用
收藏
页码:1098 / 1101
页数:4
相关论文
共 50 条
  • [11] Age Disparity in the Dissemination of Imatinib for Treating Chronic Myeloid Leukemia
    Wiggins, Charles L.
    Harlan, Linda C.
    Nelson, Harold E.
    Stevens, Jennifer L.
    Willman, Cheryl L.
    Libby, Edward N.
    Hromas, Robert A.
    AMERICAN JOURNAL OF MEDICINE, 2010, 123 (08): : 764.e1 - 764.e9
  • [12] Mechanisms of Primary and Secondary Resistance to Imatinib in Chronic Myeloid Leukemia
    Quintes-Cardama, Alfonso
    Kantarjian, Hagop M.
    Cortes, Jorge E.
    CANCER CONTROL, 2009, 16 (02) : 122 - 131
  • [13] Why Doesn't Imatinib Cure Chronic Myeloid Leukemia?
    Redner, Robert L.
    ONCOLOGIST, 2010, 15 (02): : 182 - 186
  • [14] Functional Activity of the OCT-1 Protein Is Predictive of Long-Term Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib
    White, Deborah L.
    Dang, Phuong
    Engler, Jane
    Frede, Amity
    Zrim, Stephanie
    Osborn, Michael
    Saunders, Verity A.
    Manley, Paul W.
    Hughes, Timothy P.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (16) : 2761 - 2767
  • [15] Imatinib-induced Extensive Hyperpigmentation in a Case of Chronic Myeloid Leukemia
    Balasubramanian, Pradeep
    Jagadeesan, Soumya
    Thomas, Jacob
    INDIAN JOURNAL OF DERMATOLOGY, 2015, 60 (05) : 523
  • [16] Improvement of immune thrombocytopenia with imatinib therapy following chronic myeloid leukemia
    Nakamura, Yuichi
    Itoh, Yoshihiro
    Wakimoto, Naoki
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 117 (04) : 613 - 617
  • [17] INFLUENCE OF LATE TREATMENT ON HOW CHRONIC MYELOID LEUKEMIA RESPONDS TO IMATINIB
    Costa Scerni, Ana Carolina
    Alvares, Leonardo Azevedo
    Beltrao, Ana Cristina
    Bentes, Ie Regina
    Azevedo, Tereza Cristina
    Bentes, Alessandra Quinto
    Rodrigues Lemos, Jose Alexandre
    CLINICS, 2009, 64 (08) : 731 - 734
  • [18] Molecularly targeted treatment of chronic myeloid leukemia: beyond the imatinib era
    Mughal, TI
    Goldman, JM
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2006, 11 : 209 - 220
  • [19] Phase distribution of chronic myeloid leukemia in Bangladesh
    Mottalib M.A.
    Sultana T.A.
    Khalil M.I.
    Gan S.H.
    Islam M.S.
    Choudhury S.
    Hossain M.A.
    BMC Research Notes, 7 (1)
  • [20] The Cytogenetic Landscape of Pediatric Chronic Myeloid Leukemia Diagnosed in Chronic Phase
    Karow, Axel
    Goehring, Gudrun
    Sembill, Stephanie
    Lutterloh, Friederike
    Neuhaus, Fina
    Callies, Sara
    Schirmer, Elke
    Wotschofsky, Zofia
    Roche-Lancaster, Oisin
    Suttorp, Meinolf
    Krumbholz, Manuela
    Metzler, Markus
    CANCERS, 2022, 14 (07)